Transaction Nov News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Transaction Nov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Transaction Nov Today - Breaking & Trending Today

ObsEva SA: ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million

Published: November 22, 2022

Sale of Ebopiprant royalty and milestone license to XOMA includes upfront payment of $15 million and future milestone payments of up to $98 millionThe sale proceeds are expected to enable ObsEva to resolve

Source: finanznachrichten.de

Related Topics:

Yuyuan BioscienceShauna DillonBrian OcallaghanExchange Commission OnSwiss ExchangeExchange CommissionManagement IncMerck KgaChinese National Medical Products AdministrationMerck KgaaNasdaq Stock MarketBriano CallaghanAmendment AgreementNasdaq Listing RuleNasdaq Global Select MarketDrug EvaluationChinese National Medical ProductsPrivate Securities Litigation Reform ActRisk FactorsAnnual ReportTransaction Nov